Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Crick news > Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery

Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery

Researchers at the Crick and GSK will extend their ongoing collaboration to advance the discovery of new drug targets in a £11.5million effort.
7 Apr 2021
United Kingdom
Crick news

To view this News Article

Similar stories

DeepMind will establish a research lab at the Crick, applying machine learning and artificial intelligence techniques to advance understanding of biology, including protein design … More...

The Medical Research Council, Cancer Research UK, and Wellcome have today announced £1billion of funding for the Francis… More...

We talk to Assistant Research Director Erik Sahai about his own experiences of the Crick, including why you should take … More...

Professor Nicola Lewis, an internationally recognised expert in influenza research and surveillance, has joined the Cric… More...

James Briscoe, Assistant Research Director

We talk to Assistant Research Director James Briscoe about his experiences of the Crick, including developing our resear… More...

Have your say

 
This website is powered by
ToucanTech